Peripheral IV Site Monitoring

{
  "awards": [
    {
      "aboveThreshold": true,
      "contractPeriod": {
        "endDate": "2026-09-30T23:59:59+01:00",
        "maxExtentDate": "2029-09-14T23:59:59+01:00",
        "startDate": "2025-09-15T00:00:00+01:00"
      },
      "documents": [
        {
          "datePublished": "2025-07-25T12:56:46+01:00",
          "description": "Transparency notice on Find a Tender",
          "documentType": "awardNotice",
          "format": "text/html",
          "id": "043122-2025",
          "noticeType": "UK5",
          "url": "https://www.find-tender.service.gov.uk/Notice/043122-2025"
        }
      ],
      "hasRenewal": true,
      "id": "1",
      "items": [
        {
          "additionalClassifications": [
            {
              "description": "Peripheral equipment",
              "id": "30232000",
              "scheme": "CPV"
            }
          ],
          "id": "1",
          "relatedLot": "1"
        }
      ],
      "mainProcurementCategory": "goods",
      "milestones": [
        {
          "dueDate": "2025-09-04T23:59:59+01:00",
          "id": "1",
          "status": "scheduled",
          "type": "futureSignatureDate"
        }
      ],
      "relatedLots": [
        "1"
      ],
      "renewal": {
        "description": "Allowable extension for a Framework Period to extend for a total of 4 years"
      },
      "status": "pending",
      "suppliers": [
        {
          "id": "GB-PPON-PBGH-8572-LNQT",
          "name": "HEALTHCARE 21 (UK) LIMITED"
        }
      ],
      "title": "Peripheral IV Site Monitoring",
      "value": {
        "amount": 2000000,
        "amountGross": 2400000,
        "currency": "GBP"
      }
    }
  ],
  "buyer": {
    "id": "GB-PPON-PLLH-1887-BMRL",
    "name": "SUPPLY CHAIN COORDINATION LIMITED"
  },
  "date": "2025-07-25T12:56:46+01:00",
  "id": "043122-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-0553a4",
  "parties": [
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "SE1 8UG",
        "region": "UKI45",
        "streetAddress": "Wellington House, 133-155 Waterloo Road"
      },
      "contactPoint": {
        "email": "Jennifer.Davidson@supplychain.nhs.uk",
        "name": "Jennifer Davidson"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - sub-central government",
            "id": "publicAuthoritySubCentralGovernment",
            "scheme": "UK_CA_TYPE"
          }
        ],
        "url": "https://www.supplychain.nhs.uk/"
      },
      "id": "GB-PPON-PLLH-1887-BMRL",
      "identifier": {
        "id": "PLLH-1887-BMRL",
        "scheme": "GB-PPON"
      },
      "name": "SUPPLY CHAIN COORDINATION LIMITED",
      "roles": [
        "buyer"
      ]
    },
    {
      "additionalIdentifiers": [
        {
          "id": "05020682",
          "scheme": "GB-COH"
        }
      ],
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Basingstoke",
        "postalCode": "RG24 8PZ",
        "region": "UKJ37",
        "streetAddress": "Unit B1-B2 Bond Close"
      },
      "contactPoint": {
        "email": "tenders@hc21.group"
      },
      "details": {
        "scale": "sme",
        "vcse": false
      },
      "id": "GB-PPON-PBGH-8572-LNQT",
      "identifier": {
        "id": "PBGH-8572-LNQT",
        "scheme": "GB-PPON"
      },
      "name": "HEALTHCARE 21 (UK) LIMITED",
      "roles": [
        "supplier"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "description": "This market exercise was for the provision of a solution to advise the detection of  IV infiltrations and extravasations early that includes the following:\n\u2022 Monitoring equipment and Consumables\nNHS Supply Chain have a mandate from the Department of Health and Social Care (DHSC) to drive the availability of innovative products to the NHS. NHS Supply Chain believe the product sourced by this contract (which is not covered by any of its current Framework Agreements) falls within this remit as a \u201cdisruptive\u201d innovative product and has been identified to provide enhanced patient benefits specifically;\nPatient - improving patient safety  Prevention of Never Event - which can lead to skin necrosis, Amputation, Nerve Damage for our most vulnerable patients, Neonates, paediatrics, sedated patients, critically ill and patients with cognitive deficits, along with Patients receiving Vesicant medications.\nNHS Supply Chain intends to enter into a Framework Agreement (FAG) with an identified supplier of these products/services (alongside the existing framework Infusion Pumps Administration) following a 10 calendar day publication of a Transparency notice should there only be only 1 available supplier using procedure Direct Award as defined in the Procurement Act 2023.\nThe Term of this Framework Agreement is anticipated to be 12 months, with the option to extend to a maximum term of 48 months. As part of its strategy, NHS Supply Chain anticipates engaging with suppliers of these products/services with a view to ultimately include this solution within the scope of the Framework for Infusion Pumps Administration Sets and Associated products which is due to renewal on 30th September 2026\nThe Framework Agreement will be between NHS Supply Chain and the Supplier, however 1) NHSSC, 2) any NHS Trust; 3) any other NHS entity; 4) any government department, agency or other statutory body and/or 5) any private sector entity active in the UK healthcare sector will be able to enter into a direct contract with the Supplier for any of the supplies and/or services under the Framework.\nElectronic ordering will be used, and electronic invoicing will be accepted, and electronic payment will be used.\nFor the avoidance of doubt and notwithstanding the estimate indicated, NHSSC does not guarantee any level of purchase through the framework and advises applicants that the framework shall be established on a non-exclusive basis.",
    "documents": [
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      }
    ],
    "id": "1587",
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "id": "1",
        "status": "complete",
        "suitability": {
          "sme": true,
          "vcse": true
        }
      }
    ],
    "participationFees": [
      {
        "description": "0",
        "id": "ocds-h6vhtk-0553a4",
        "type": [
          "win"
        ]
      }
    ],
    "procurementMethod": "direct",
    "procurementMethodDetails": "Direct award",
    "procurementMethodRationale": "Traditional methods rely on periodic clinician assessments, which can miss early signs of infiltration or extravasation, leading to serious complications such as skin necrosis, nerve damage, or medication dosing errors.  The ivWatch Patient Monitoring System provides continuous, non-invasive monitoring using optical sensor technology and proprietary algorithms to detect infiltrations at their earliest stages, often before visible signs are present. iv.Watch technology has demonstrated exceptional clinical value in preventing infiltration and extravasation injuries associated with peripheral intravenous (PIV) therapy. This innovation enhances patient safety, reduces liability, and complements clinician assessments, addressing the limitations of periodic monitoring. \nResearch has been carried out on the benefits of the iv Watch technology and can be found in the British Journal of Nursing: British Journal of Nursing - Addressing and mitigating the high costs of extravasation and infiltration to patients and healthcare organisations \nDue to the absence of competition for technical reasons and that the Manufacturer is only just entering the UK market, only this supplier/distributor can supply the goods required. \nProcurement Act 2023, Section 41, Schedule 5, Section 5 (b) \n\u201cThere are no reasonable alternatives to those goods, services or works\u201d",
    "procurementMethodRationaleClassifications": [
      {
        "id": "singleSuppliersTechnicalReasons"
      }
    ],
    "status": "complete",
    "techniques": {
      "frameworkAgreement": {
        "buyerCategories": "The Framework will be between the Authority and individual Supplier(s). The Authority will be entitled to purchase Goods and/or Services which we will make available for purchase by:\n-any NHS Trust;\n-any other NHS entity; \n-any government department, agency or other statutory body (for the avoidance of doubt including local authorities) and/or \n-any private sector entity active in the UK healthcare sector.",
        "buyerLocationRestrictions": [
          {
            "gazetteer": {
              "identifiers": [
                "UK"
              ],
              "scheme": "GB-ITL"
            }
          }
        ],
        "periodRationale": "n/a",
        "type": "open"
      },
      "hasFrameworkAgreement": true
    },
    "title": "Peripheral IV Site Monitoring"
  }
}